Loading
All products are for in-vitro research and laboratory use only — not for human consumption
Loading

Triple agonist (GIP/GLP-1/Glucagon) for advanced metabolic research.
Retatrutide is a novel triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor approach represents the next generation of incretin-based compounds for metabolic pathway research.
Storage: Store at 2-8°C. Reconstituted solution stable for 21 days at 2-8°C. Do not freeze.
All products on this site are for Research and Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.